BioCentury
ARTICLE | Company News

Pipex submits Coprexa NDA

November 30, 2007 2:41 AM UTC

PP submitted an NDA to FDA for Coprexa oral tetrathiomolybdate to treat initially presenting neurologic Wilson's disease. The anti-copper agent has Orphan Drug designation in the U.S. Wilson's Disease...